ATE68700T1 - Nichttoxische ophthalmische zubereitungen und verfahren zu ihrer herstellung. - Google Patents
Nichttoxische ophthalmische zubereitungen und verfahren zu ihrer herstellung.Info
- Publication number
- ATE68700T1 ATE68700T1 AT86304037T AT86304037T ATE68700T1 AT E68700 T1 ATE68700 T1 AT E68700T1 AT 86304037 T AT86304037 T AT 86304037T AT 86304037 T AT86304037 T AT 86304037T AT E68700 T1 ATE68700 T1 AT E68700T1
- Authority
- AT
- Austria
- Prior art keywords
- manufacture
- processes
- ophthalmic preparations
- preparation
- optionally
- Prior art date
Links
- 238000002360 preparation method Methods 0.000 title abstract 4
- 238000004519 manufacturing process Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 231100000252 nontoxic Toxicity 0.000 title 1
- 230000003000 nontoxic effect Effects 0.000 title 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 abstract 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 abstract 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 abstract 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 abstract 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 abstract 1
- 239000011575 calcium Substances 0.000 abstract 1
- 229910052791 calcium Inorganic materials 0.000 abstract 1
- 239000000470 constituent Substances 0.000 abstract 1
- 210000002175 goblet cell Anatomy 0.000 abstract 1
- GVALZJMUIHGIMD-UHFFFAOYSA-H magnesium phosphate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O GVALZJMUIHGIMD-UHFFFAOYSA-H 0.000 abstract 1
- 229960002261 magnesium phosphate Drugs 0.000 abstract 1
- 229910000157 magnesium phosphate Inorganic materials 0.000 abstract 1
- 239000004137 magnesium phosphate Substances 0.000 abstract 1
- 235000010994 magnesium phosphates Nutrition 0.000 abstract 1
- 238000012423 maintenance Methods 0.000 abstract 1
- 210000003097 mucus Anatomy 0.000 abstract 1
- 239000002674 ointment Substances 0.000 abstract 1
- 239000011591 potassium Substances 0.000 abstract 1
- 229910052700 potassium Inorganic materials 0.000 abstract 1
- 239000011734 sodium Substances 0.000 abstract 1
- 229910052708 sodium Inorganic materials 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US73895385A | 1985-05-29 | 1985-05-29 | |
| EP86304037A EP0205279B1 (de) | 1985-05-29 | 1986-05-28 | Nichttoxische ophthalmische Zubereitungen und Verfahren zu ihrer Herstellung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE68700T1 true ATE68700T1 (de) | 1991-11-15 |
Family
ID=24970192
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT86304037T ATE68700T1 (de) | 1985-05-29 | 1986-05-28 | Nichttoxische ophthalmische zubereitungen und verfahren zu ihrer herstellung. |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US4775531A (de) |
| EP (1) | EP0205279B1 (de) |
| JP (1) | JPH07108856B2 (de) |
| AT (1) | ATE68700T1 (de) |
| CA (1) | CA1263606A (de) |
| DE (1) | DE3682117D1 (de) |
Families Citing this family (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0362277A4 (en) * | 1987-06-01 | 1990-11-28 | Allergan, Inc | Preservative free ophthalmic ointments |
| US5221537A (en) * | 1988-09-02 | 1993-06-22 | Gerald Hecht | Tissue irrigating solutions |
| US5460834A (en) * | 1991-12-13 | 1995-10-24 | Alcon Laboratories, Inc. | Combinations of polymers for use in physiological tear compositions |
| EP0546728A3 (en) * | 1991-12-13 | 1993-09-08 | Alcon Laboratories Inc | Physiological tear compositions and methods for their preparation |
| US5290572A (en) * | 1992-08-06 | 1994-03-01 | Deo Corporation | Opthalmic composition for treating dry eye |
| US5830508A (en) * | 1992-08-06 | 1998-11-03 | Deo Corporation | Composition for treating dry eye |
| CN1045383C (zh) * | 1993-04-07 | 1999-10-06 | 王慧康 | 用于治疗老年性白内障的药物组合物 |
| US5545617A (en) * | 1993-11-12 | 1996-08-13 | The Schepens Eye Research Institute, Inc. | Therapeutic regulation of abnormal conjunctival goblet cell mucous secretion |
| CA2134376C (en) * | 1993-12-20 | 2001-10-23 | Haresh G. Bhagat | Combinations of polymers for use in physiological tear compositions |
| IT1273011B (it) | 1994-07-25 | 1997-07-01 | Trhecnopharma S A | Preparato oftalmico per l'uso come lacrima artificiale |
| US5767105A (en) * | 1995-05-03 | 1998-06-16 | Peyman; Gholam A. | Ocular solution |
| JP3058920B2 (ja) * | 1996-04-19 | 2000-07-04 | 一男 坪田 | アルブミンを有効成分とする医薬組成物 |
| DE69840003D1 (de) * | 1997-10-27 | 2008-10-23 | Otsuka Pharma Co Ltd | Verpackung mit ophtalmischen perfusat und reinigungsflüssigkeit |
| US6455583B1 (en) * | 1998-05-08 | 2002-09-24 | The University Of Miami | Method for treating meibomian gland disease |
| US6432934B1 (en) | 1998-08-06 | 2002-08-13 | Advanced Vision Research | Methods and compositions for topical treatment of eye surface inflammation and related dry eye disease |
| US6153582A (en) * | 1998-11-05 | 2000-11-28 | Bausch & Lomb Surgical, Inc. | Defined serumfree medical solution for ophthalmology |
| US7524511B1 (en) * | 2000-07-12 | 2009-04-28 | Rogue Valley Natural Springs, Inc. | Method and kit for moisturizing the surface of the eye |
| US20050031540A1 (en) * | 2001-11-20 | 2005-02-10 | Nielsen Per Julius | Visco dye |
| US8420699B1 (en) | 2002-06-19 | 2013-04-16 | Irvine L. Dubow | Composition and methods of treatment using deionized and ozonated solution |
| US7897642B1 (en) * | 2002-06-19 | 2011-03-01 | Dr. Irvine Dubow | Compositions and methods for dry eye syndrome |
| EP1539124B1 (de) * | 2002-09-05 | 2018-07-18 | Vanderbilt Royalty Sub L.P. | Zusammensetzungen und sets zur entfernung von reizenden verbindungen von körperoberflächen |
| US9297928B2 (en) * | 2004-11-22 | 2016-03-29 | Johnson & Johnson Vision Care, Inc. | Ophthalmic compositions comprising polyether substituted polymers |
| EP1848749B1 (de) * | 2005-02-04 | 2018-10-31 | Auburn University | Kontaktstofffreisetzungssystem |
| US8388995B1 (en) | 2006-02-03 | 2013-03-05 | Auburn University | Controlled and extended delivery of hyaluronic acid and comfort molecules via a contact lens platform |
| US8349352B2 (en) * | 2005-02-04 | 2013-01-08 | Auburn University | Therapeutic contact lenses with anti-fungal delivery |
| US9238003B2 (en) | 2005-02-04 | 2016-01-19 | Auburn University | Extended or continuous wear silicone hydrogel contact lenses for the extended release of comfort molecules |
| ES2353399T3 (es) * | 2005-04-01 | 2011-03-01 | Neurogesx, Inc. | Aceites de capsaicinoides y métodos para obtenerlos y usarlos. |
| CN101242825B (zh) * | 2005-07-01 | 2011-03-30 | 希格马托制药工业公司 | L-肉碱和/或烷酰基l-肉碱用于制备滴眼剂形式的眼用生理学补充剂或药物的用途 |
| US20070207116A1 (en) * | 2006-03-01 | 2007-09-06 | Brown David C | Antioxidant compositions for the eye |
| US20080138408A1 (en) * | 2006-11-13 | 2008-06-12 | Siddharth Venkatesh | Drug delivery system and method |
| US8163358B2 (en) * | 2009-02-18 | 2012-04-24 | Synergeyes, Inc. | Surface modification of contact lenses |
| JP4644305B1 (ja) * | 2010-05-12 | 2011-03-02 | 喜美雄 川村 | 点眼薬及びその製造方法 |
| WO2013046059A2 (en) * | 2011-09-27 | 2013-04-04 | Sykora Robert C | Methods and compositions for tamarind-based ocular disease treatment in combination with trehalose |
| WO2014190141A1 (en) * | 2013-05-23 | 2014-11-27 | Stone Ralph P | Scleral lens solution |
| EP2999775A4 (de) * | 2013-05-23 | 2016-06-08 | Smm Ventures Llc | Sklerallinsenslösung |
| EP3525799B1 (de) * | 2016-10-14 | 2022-01-26 | i.com Medical GmbH | Verfahren zur herstellung, wiederherstellung und erhaltung von homöostase der augenoberfläche |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2547653A (en) * | 1948-03-10 | 1951-04-03 | Bradford R Minnis | Fluid for use in contact with the human eyeball |
| US3676553A (en) * | 1969-12-15 | 1972-07-11 | Cybersol | Therapeutic composition |
| US3821368A (en) * | 1971-06-01 | 1974-06-28 | Cybersal Inc | Therapeutic composition |
| US3897550A (en) * | 1971-06-01 | 1975-07-29 | Cybersol | Method for administering water soluble drugs, nutrients and other solutes to a mammal |
| US3843782A (en) * | 1971-07-26 | 1974-10-22 | Flow Pharma Inc | Eye solution and method of using same |
| US4371522A (en) * | 1979-04-25 | 1983-02-01 | Gilbard Jeffrey P | Keratoconjunctivitis sicca therapy |
| US4550022A (en) * | 1981-10-05 | 1985-10-29 | Alcon Laboratories, Inc. | Tissue irrigating solution |
| US4443432A (en) * | 1981-10-05 | 1984-04-17 | Alcon Laboratories, Inc. | Ophthmalic irrigating solution |
| JPS59101421A (ja) * | 1982-11-29 | 1984-06-12 | Kaken Pharmaceut Co Ltd | 眼科用潅流液 |
-
1986
- 1986-05-23 CA CA000509818A patent/CA1263606A/en not_active Expired
- 1986-05-28 JP JP61121405A patent/JPH07108856B2/ja not_active Expired - Lifetime
- 1986-05-28 DE DE8686304037T patent/DE3682117D1/de not_active Expired - Lifetime
- 1986-05-28 EP EP86304037A patent/EP0205279B1/de not_active Expired - Lifetime
- 1986-05-28 AT AT86304037T patent/ATE68700T1/de not_active IP Right Cessation
- 1986-10-06 US US06/915,903 patent/US4775531A/en not_active Expired - Lifetime
-
1988
- 1988-08-16 US US07/232,752 patent/US4911933A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| EP0205279A1 (de) | 1986-12-17 |
| US4775531A (en) | 1988-10-04 |
| CA1263606A (en) | 1989-12-05 |
| JPS6226225A (ja) | 1987-02-04 |
| DE3682117D1 (de) | 1991-11-28 |
| EP0205279B1 (de) | 1991-10-23 |
| US4911933A (en) | 1990-03-27 |
| JPH07108856B2 (ja) | 1995-11-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE68700T1 (de) | Nichttoxische ophthalmische zubereitungen und verfahren zu ihrer herstellung. | |
| IL97538A0 (en) | Liposomes containing an aminoglycoside salt and their preparation | |
| PL309753A1 (en) | Ophthalmic preparation used to produce artificial tears | |
| AU687112B2 (en) | Methods for increasing extracellular adenosine and for stabilization mast cells | |
| FR2560523B1 (fr) | Solution ophtalmique contenant du pranoprofene et de l'acide borique | |
| ATE265856T1 (de) | Augenlösung mit tetracyclin für behandlung von trockenen augen | |
| EP0157476A3 (en) | Improvements in or relating to ophthalmic lenses | |
| GB2187955B (en) | Improvements in or relating to the treatment of sickle cell disease | |
| DE3777611D1 (de) | Lysozyme hydrochlorid und dikaliumglycyrrhizinat enthaltende loesung. | |
| FI886050A7 (fi) | Amperometrinen menetelmä 1,4-dihydronikotiiniamidiadeniinidinukleotidin (NADH) kvantitatiiviseksi määrittämiseksi liuoksessa | |
| ATE95564T1 (de) | Aeusseres membranprotein f von pseudomonas aeruginosa. | |
| ATE10573T1 (de) | Salzgemisch, verfahren zu seiner herstellung und verwendung. | |
| CA2001552A1 (en) | Cyclophosphamide - sodium bicarbonate lyophilizates | |
| ES2127726T3 (es) | Un metodo para la preparacion de hemoglobina piridoxilada. | |
| DE58903876D1 (de) | Riboflavin-4'5'-cyclo-phosphorsaeureesterchlorid, dessen herstellung und verwendung zur herstellung von riboflavin-5'-phosphat (5'-fmn) bzw. dessen natriumsalz. | |
| PT81970B (pt) | Processo para a preparacao de um reagente para a dosagem, por hemaglutinacao, de anticorpos contra as toxinas bacterianas | |
| AU562517B2 (en) | Biostimulating agent containing creatine | |
| DK251284A (da) | Substituerede 1,2,3-triazino(4',5'.4,5)thieno(2,3-b)-quinolin-4(3h)-oner eller syreadditionssalte deraf og deres fremstilling | |
| AU1043388A (en) | Improvements in or relating to spectacles | |
| JPS5664784A (en) | Cultivating method of chlorella at high concentration | |
| FR2594694B3 (fr) | Association renfermant a titre de principes actifs, un agent mucolytique et l'acide adenosine triphosphorique ou un de ses sels | |
| DE68905796D1 (de) | Chromoglycinsaeure-natriumsalz enthaltende aerosolzubereitungen. | |
| Chollet et al. | Isolation of a Stable Enzyme multiplied by super (14) CO sub (2) multiplied by Mg super (2+) multiplied by Carboxyarabinitol Bisphosphate Complex With Ribulosebisphosphate Carboxylase From Chromatium vinosum. | |
| ES8604885A2 (es) | Mejoras en el objeto de la patente de invencion n 527.268 que se refiere a procedimiento de obtencion de nuevos derivados imidazolicos del acido 2-hidroxibenzoico | |
| ES512751A0 (es) | "procedimiento para la preparacion de un colirio antiseptico para afecciones oculares". |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |